Zenas BioPharma, Inc.
NASDAQ:ZBIOBiotechnology
Healthcare
$25.04 +3.46%
+$0.64 today
- Market cap
- $1.70B
- Beta
- -0.69
- P/E (TTM)
- -2.5
- EPS (TTM)
- -$7.64
52W Low $8.91High $44.60
Volume 0.27M
Average 0.71M
Balance Sheet
Inspect the capital base behind the business.
Assets
$383.64M
FY 2025 · Annual
+3.7% YoYLiabilities
$141.50M
FY 2025 · Annual
+146.0% YoYEquity
$242.14M
FY 2025 · Annual
-22.5% YoYBalance Sheet
USD
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $500.2M |
| Short-term Investments | $217.0M |
| Receivables | $1.1M |
| Other Current | $11.9M |
| Total Current Assets | $730.2M |
| PP&E (Net) | $1.1M |
| Long-term Investments | $1.3M |
| Other Non-current | $15.1M |
| Total Non-current Assets | $17.5M |
| Total Assets | $747.7M |
Analysis
Selected assets total $747.7M for Latest. The largest visible component is Cash & Equivalents at $500.2M, about 66.9% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 8-K | Current report | Nov 6, 2026 | |
| 424B5 | 424B5 filing | Nov 6, 2026 | |
| SC 13G/A | SC 13G/A filing | Nov 5, 2026 | |
| 8-K | Current report | Nov 5, 2026 | |
| 10-Q | Quarterly report | Nov 5, 2026 |
How much cash does ZBIO have?
Zenas BioPharma, Inc. (ZBIO) reported $110.64M in cash and equivalents in fiscal 2025.
How much debt does ZBIO carry?
Zenas BioPharma, Inc. (ZBIO) reported $79.96M of total debt, with net debt of -$30.68M.
Continue the stock analysis
Jump to another research area for this company.